Doherty Clinical Trials CEO Dr Andrew Brockway said, “We are passionate about the development of new medicines for diseases with unmet medical needs and are excited to support Noxopharm through our extensive know-how and network of collaborators.” …
Latest Video
New Stories
-
Medicines funded by Pharmac tops 50 since last year's budget boost
March 13, 2025 - - Latest News -
Australian company confirms the location of key clinical trial
March 13, 2025 - - Australian Biotech -
Australia is not alone in using rebate payments, but there are some differences
March 13, 2025 - - Latest News -
New technology hits Australia for type 1 diabetes patients
March 12, 2025 - - Latest News -
'What I love about this event is that it brings together a community of people who otherwise feel quite isolated'
March 11, 2025 - - Latest News -
The terrible events of 2023 were born of a decade-old policy failure
March 11, 2025 - - Latest News -
The key is leading with good ideas that will make the system better
March 11, 2025 - - Latest News